NRAS mutation (22%) was more common than KRAS mutation (15%), but co‐mutations in both NRAS and KRAS were found in 50% and 75% of NRAS‐ and KRAS‐mutated T‐ALL cases. This evidence concerns the gene KRAS and acute lymphoblastic leukemia.